Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes

References

• Cheng ZJ, Vapaatalo H, Mervaala E. Angiotensin II and vascular inflammation. Med Sci Monit. 2005;11:RA194–RA205.
   PubMed Web of Science ®Google Scholar
• Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res. 2006;71:247–258.
   PubMed Web of Science ®Google Scholar
• Verlohren S, Muller DN, Luft FC, Dechend R. Immunology in hypertension, preeclampsia, and target-organ damage. Hypertension. 2009;54:439–443.
   PubMed Web of Science ®Google Scholar
• Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: Linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res. 2008;102:488–496.
   PubMed Web of Science ®Google Scholar
• Westhoff JH, Hilgers KF, Steinbach MP, Hartner A, Klanke B, Amann K, Melk A. Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a. Hypertension. 2008;52:123–129.
   PubMed Web of Science ®Google Scholar
• Boily G, Seifert EL, Bevilacqua L, He XH, Sabourin G, Estey C, . SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One. 2008;3:e1759.
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Yoshikawa K. Necdin regulates p53 acetylation via Sirtuin1 to modulate DNA damage response in cortical neurons. J Neurosci. 2008;28:8772–8784.
   PubMed Web of Science ®Google Scholar
• Vahtola E, Louhelainen M, Merasto S, Martonen E, Penttinen S, Aahos I, . Forkhead class O transcription factor 3a activation and Sirtuin1 overexpression in the hypertrophied myocardium of the diabetic Goto-Kakizaki rat. J Hypertens. 2008;26:334–344.
   PubMed Web of Science ®Google Scholar
• Borradaile NM, Pickering JG. NAD (+), sirtuins, and cardiovascular disease. Curr Pharm Des. 2009;15:110–117.
   PubMed Web of Science ®Google Scholar
• Oliva J, French BA, Li J, Bardag-Gorce F, Fu P, French SW. Sirt1 is involved in energy metabolism: The role of chronic ethanol feeding and resveratrol. Exp Mol Pathol. 2008;85: 155–159.
   PubMed Web of Science ®Google Scholar
• Ghosh HS. The anti-aging, metabolism potential of SIRT1. Curr Opin Investig Drugs. 2008;9:1095–1102.
   PubMedGoogle Scholar
• Alcaín FJ, Villalba JM. Sirtuin activators. Expert Opin Ther Pat. 2009;19:403–414.
   PubMed Web of Science ®Google Scholar
• Shin SM, Cho IJ, Kim SG. Resveratrol protects mitochondria against oxidative stress through AMPK-mediated GSK3 {beta} inhibition downstream of poly[ADP-ribose]polymerase-LKB1 pathway. Mol Pharmacol. 2009;76:884–895.
   PubMed Web of Science ®Google Scholar
• Hossain MB, Ji P, Anish R, Jacobson RH, Takada S. Polymerase 1 Interacts with nuclear respiratory factor 1 [NRF-1] and plays a role in NRF-1 transcriptional Regulation. J Biol Chem. 2009;284:8621–8632.
   PubMed Web of Science ®Google Scholar
• Viña J, Gomez-Cabrera MC, Borras C, Froio T, Sanchis-Gomar F, Martinez-Bello VE, . Mitochondrial biogenesis in exercise and in ageing. Adv Drug Deliv Rev. 2009;61:1369–1374.
   PubMed Web of Science ®Google Scholar
• Bohlender J, Fukamizu A, Lippoldt A, Nomura T, Dietz R, Ménard J, . High human renin hypertension in transgenic rats. Hypertension. 1997;29:428–434.
   PubMed Web of Science ®Google Scholar
• Ganten D, Wagner J, Zeh K, Bader M, Michel JB, Paul M, . Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc Natl Acad Sci USA. 1992;89:7806–7810.
   PubMed Web of Science ®Google Scholar
• Louhelainen M, Vahtola E, Kaheinen P, Leskinen H, Merasto S, Kytö V, . Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats. Br J Pharmacol. 2007;150:851–861.
   PubMed Web of Science ®Google Scholar
• Heyen JR, Blasi ER, Nikula K, Rocha R, Daust HA, Frierdich G, . Structural, functional, and molecular characterization of the SHHF model of heart failure. Am J Physiol Heart Circ Physiol. 2002;283:H1775–H1784.
   PubMed Web of Science ®Google Scholar
• Bastide K, Guilly MN, Bernaudin JF, Joubert C, Lectard B, Levalois C, . Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors. Lung Cancer. 2009;63:348–353.
   PubMed Web of Science ®Google Scholar
• Wellner M, Dechend R, Park JK, Shagdarsuren E, Al-Saadi N, Kirsch T, . Cardiac gene expression profile in rats with terminal heart failure and cachexia. Physiol Genomics. 2005;20:256–267.
   PubMed Web of Science ®Google Scholar
• Chlopčíková S, Psotová J, Miketová P. Neonatal rat cardiomyocytes – A model for the study of morphological, biochemical and electrophysiological characteristics of the heart. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2001;145:49–55.
   PubMedGoogle Scholar
• Rapp JP, Dene H. Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension. 1985;7:340–349.
   PubMed Web of Science ®Google Scholar
• Walder RY, Morgan DA, Haynes WG, Sigmund RD, McClain AM, Stokes JB, . Genetic characterization of the “new” Harlan Sprague–Dawley Dahl salt-sensitive rats. Hypertension. 1996;27:546–551.
   PubMed Web of Science ®Google Scholar
• Csiszar A, Labinskyy N, Olson S, Pinto JT, Gupte S, Wu JM, . Resveratrol induces mitochondrial biogenesis in endothelial cells, Am J Physiol Heart Circ Physiol. 2009;297:H13–H20.
   PubMed Web of Science ®Google Scholar
• Müller DN, Mervaala EM, Dechend R, Fiebeler A, Park JK, Schmidt F, . Angiotensin II (AT (1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy. Am J Pathol. 2000;157:111–122.
   PubMed Web of Science ®Google Scholar
• Muller DN, Shagdarsuren E, Park JK, Dechend R, Mervaala E, Hampich F, . Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol. 2002;161:1679–1693.
   PubMed Web of Science ®Google Scholar
• Helkamaa T, Finckenberg P, Louhelainen M, Merasto S, Rauhala P, Lapatto R, . Entacapone protects from angiotensin II-induced inflammation and renal injury. J Hypertens. 2003;21:2353–2363.
   PubMed Web of Science ®Google Scholar
• Yamamoto E, Kataoka K, Yamashita T, Tokutomi Y, Dong YF, Matsuba S, . Role of xanthine oxidoreductase in the reversal of diastolic heart failure by candesartan in the salt-sensitive hypertensive rat. Hypertension 2007;50:657–662.
   PubMed Web of Science ®Google Scholar
• Finkel T, Deng CX, Mostoslavsky. Recent progress in the biology and physiology of sirtuins. Nature 2009;460: 587–591.
   PubMed Web of Science ®Google Scholar
• Civitarese AE, Carling S, Heilbronn LK, Hulver MH, Ukropcova B, Deutsch WA, . CALERIE Pennington Team. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 2007;4:e76.
   PubMed Web of Science ®Google Scholar
• Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, . Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res. 2007;100:1512–1521.
   PubMed Web of Science ®Google Scholar
• López-Lluch G, Irusta PM, Navas P, de Cabo R, Mitochondrial biogenesis and healthy aging. Exp Gerontol. 2008;43:813–819.
   PubMed Web of Science ®Google Scholar
• Borra MT, Smith BC, Denu JM. Mechanisms of human SIRT1 activation by resveratrol. J Biol Chem. 2005;280: 17187–17195.
   PubMed Web of Science ®Google Scholar
• Kaeberlein M, McDonaugh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, . Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 2005;280:17038–17045.
   PubMed Web of Science ®Google Scholar
• Haigis MC, Sinclair DA. Mammalian sirtuins: Biological insights and disease relevance. Annu Rev Pathol. 2010;5: 253–295.
   PubMed Web of Science ®Google Scholar
• Stevens MJ, Li F, Drel VR, Abatan OI, Kim H, Burnett D, . Nicotinamide reverses neurological and neurovascular deficits in streptozotocin diabetic rats. J Pharmacol Exp Ther. 2007;320:458–464.
   PubMed Web of Science ®Google Scholar
• J Huang D, Wang Y, Yang C, Liao Y, Huang K. Angiotensin II promotes poly[ADP-ribosyl]ation of c-Jun/c-Fos in cardiac fibroblasts. Mol Cell Cardiol. 2009;46:25–32.
   PubMed Web of Science ®Google Scholar
• Pillai JB, Gupta M, Rajamohan SB, Lang R, Raman J, Gupta MP. Poly (ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol. 2006;291:H1545–H1553.
   PubMed Web of Science ®Google Scholar
• Rajamohan SB, Pillai VB, Gupta M, Sundaresan NR, Birukov KG, Samant S, . SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly (ADP-ribose) polymerase 1. Mol Cell Biol. 2009;29:4116–4129.
   PubMed Web of Science ®Google Scholar
• Mervaala E, Biala A, Merasto S, Lempiäinen J, Mattila I, Martonen E, . Metabolomics in angiotensin II-induced cardiac hypertrophy. Hypertension. 2010;55:508–515.
   PubMed Web of Science ®Google Scholar
• Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, . Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006;127:1109–1122.
   PubMed Web of Science ®Google Scholar
• Fiebeler A, Schmidt F, Müller DN, Park JK, Dechend R, Bieringer M, . Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury. Hypertension 2001;37:787–793.
   PubMed Web of Science ®Google Scholar
• Miyazaki R, Ichiki T, Hashimoto T, Inanaga K, Imayama I, Sadoshima J, Sunagawa K. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2008;28:1263–1269.
   PubMed Web of Science ®Google Scholar